In accordance with 5 CFR 1320, the information collection is approved for three years.
In future collections, costs and time burden estimates should be rounded to the appropriate
number of significant digits. If "reading instructions" are provided as potential time or cost
burdens, then the location of the instructions or the instructions themselves should be
provided. Also, the burden for refreshing on instructions should be included, as appropriate.
Any detailed tables should be provided in excel format along with or in lieu of detailed tables
provided within the supporting statement.
Inventory as of this Action
Requested
Previously Approved
05/31/2018
36 Months From Approved
05/31/2015
250
0
249
44,266
0
44,266
112,266
0
112,266
The NESHAP for Pharmaceuticals Production were proposed on April 2, 1997, and promulgated on September 21, 1998. In general, all NESHAP standards require initial notifications, performance tests, and periodic reports. Owners or operators are also required to maintain records of the occurrence and duration of any malfunctions in the operation of an affected facility, or any period during which the monitoring system is inoperative. These notifications, reports, and records are essential in determining compliance and, in general, are required of all sources subject to NESHAP. This information is used by the Agency to identify sources subject to the standards to insure that the maximum achievable control technologies are being applied. Semiannual summary reports are also required.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
1781ss07.docx
NESHAP for Pharmaceuticals Production (40 CFR Part 63, Subpart GGG)